NEW YORK (GenomeWeb) – Cellular Dynamics will supply its iCell products for drug discovery to Roche and collaborate on identifying novel drug candidates, the company said today.

Under the terms of the agreement, Roche will have exclusive access to certain iCell products, derived from induced pluripotent stem cells (iPSCs), for use in high-throughput screening and lead optimization for drug discovery.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.